What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2015 Referencia Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub 2015 Jan 14. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s13402-014-0203-7 Revista CELL ONCOL Títol Complet Intrinsic cancer subtypes--next steps into personalized medicine. Codi 54447 PMID https://pubmed.ncbi.nlm.nih.gov/25586691 Nom Autors Dienstmann, Rodrigo; Grasselli, Julieta; Moreno, Victor; Nadal, Ernest; Pernas, Sonia; Salazar, Ramon; Santos, Cristina; Sanz-Pamplona, Rebeca; Tabernero, Josep et al. DOI número 10.1007/s13402-014-0203-7 Year 2015 Referencia J Clin Oncol. 2015 Jun 1;33(16):1787-96. doi: 10.1200/JCO.2014.60.0213. Epub 2015 Apr 27. Tipus publicació Review in national publication DOI http://dx.doi.org/10.1200/JCO.2014.60.0213 Revista J CLIN ONCOL Títol Complet Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. Codi 54446 PMID https://pubmed.ncbi.nlm.nih.gov/25918287 Nom Autors Dienstmann, Rodrigo; Salazar, Ramon; Tabernero, Josep et al. DOI número 10.1200/JCO.2014.60.0213 Year 2015 Referencia Clin Cancer Res. 2015 Nov 1;21(21):4811-8. doi: 10.1158/1078-0432.CCR-14-3222. Epub 2015 Jul 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1078-0432.CCR-14-3222 Revista CLIN CANCER RES Títol Complet SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial. Codi 54445 PMID https://pubmed.ncbi.nlm.nih.gov/26169969 Nom Autors Brachmann, Carrie B; Heise, Carla; Hidalgo, Manuel; Illei, Peter; Lopez-Casas, Pedro P; Lopez-Rios, Fernando; Menendez, Camino; Musteanu, Monica; Pierce, Daniel; Plaza, Carlos et al. DOI número 10.1158/1078-0432.CCR-14-3222 Year 2015 Referencia Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)70127-0 Revista LANCET ONCOL Títol Complet Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Codi 54444 PMID https://pubmed.ncbi.nlm.nih.gov/25877855 Nom Autors Achille, Emmanuel; Acs, Peter; Ahn, Joong Bae; Al-batran, Salah-eddin; Anderson, Thomas; Andrews, Willard; Atkinson, Victoria; Awasthi, Sanjay; Ayers, John; Azad, Niolfer et al. DOI número 10.1016/S1470-2045(15)70127-0 Year 2015 Referencia N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309. Tipus publicació Clinical guide DOI http://dx.doi.org/10.1056/NEJMoa1502309 Revista NEW ENGL J MED Títol Complet Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. Codi 54443 PMID https://pubmed.ncbi.nlm.nih.gov/26287849 Nom Autors Baselga, Jose; Blay, Jean-Yves; Chan, Emily; Chau, Ian; Diamond, Eli L; Elez-Fernandez, Maria Elena; Faris, Jason E; Gervais, Radj; Hidalgo, Manuel; Hofheinz, Ralf-Dieter et al. DOI número 10.1056/NEJMoa1502309 Year 2015 Referencia Cancer Discov. 2015 Jun;5(6):598-609. doi: 10.1158/2159-8290.CD-14-1432. Epub 2015 May 11. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/2159-8290.CD-14-1432 Revista CANCER DISCOV Títol Complet Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer. Codi 54442 PMID https://pubmed.ncbi.nlm.nih.gov/25962717 Nom Autors Argiles, Guillem; Benavent, Marta; Braun, Stephan; Cervantes, Andres; Dienstmann, Rodrigo; Garcia-Carbonero, Rocio; Hald, Rikke; Hansen, Ulla H; Horak, Ivan D; Kragh, Michael et al. DOI número 10.1158/2159-8290.CD-14-1432 Year 2015 Referencia Lancet Oncol. 2015 Aug;16(8):937-48. doi: 10.1016/S1470-2045(15)00138-2. Epub 2015 Jul 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)00138-2 Revista LANCET ONCOL Títol Complet Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial. Codi 54441 PMID https://pubmed.ncbi.nlm.nih.gov/26184520 Nom Autors Adenis, Antoine; Barone, Carlo; Bouche, Olivier; Falcone, Alfredo; Goldberg, Richard M; Grothey, Axel; Humblet, Yves; Jeffers, Michael; Laurent, Dirk; Lenz, Heinz-Josef et al. DOI número 10.1016/S1470-2045(15)00138-2 Year 2015 Referencia N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1056/NEJMoa1414325 Revista NEW ENGL J MED Títol Complet Randomized trial of TAS-102 for refractory metastatic colorectal cancer. Codi 54440 PMID https://pubmed.ncbi.nlm.nih.gov/25970050 Nom Autors Adenis, Antoine; Andre, Thierry; Baba, Hideo; Baron, Ari D; Benavides, Manuel; Benedetti, Fabio; Bertolini, Alessandro; Bird, Brian; Block, Andreas; Borg, Christophe et al. DOI número 10.1056/NEJMoa1414325 Year 2015 Referencia Cancer Discov. 2015 Nov;5(11):1164-77. doi: 10.1158/2159-8290.CD-15-0369. Epub 2015 Sep 26. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/2159-8290.CD-15-0369 Revista CANCER DISCOV Títol Complet Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Autors Elena Antima Martinez Saez Codi 54439 PMID https://pubmed.ncbi.nlm.nih.gov/26410082 Nom Autors Barker, Frederick G 2nd; Baselga, Jose; Batchelor, Tracy T; Beroukhim, Rameen; Brastianos, Priscilla K; Cahill, Daniel P; Carter, Scott L; Chevalier, Aaron; Choueiri, Toni K; Cibulskis, Kristian et al. DOI número 10.1158/2159-8290.CD-15-0369 Year 2015 Referencia Am Soc Clin Oncol Educ Book. 2015;35:e149-56. doi: 10.14694/EdBook_AM.2015.35.e149. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.14694/EdBook_AM.2015.35.e149 Revista American Society of Clinical Oncology educational Títol Complet Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer. Codi 54438 PMID https://pubmed.ncbi.nlm.nih.gov/25993166 Nom Autors Dienstmann, Rodrigo; Salazar, Ramon; Tabernero, Josep et al. DOI número 10.14694/EdBook_AM.2015.35.e149 Year 2015 Referencia Target Oncol. 2015 Mar;10(1):111-23. doi: 10.1007/s11523-014-0320-2. Epub 2014 Jun 15. Tipus publicació Clinical Trials DOI http://dx.doi.org/10.1007/s11523-014-0320-2 Revista TARGET ONCOL Títol Complet Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Codi 54437 PMID https://pubmed.ncbi.nlm.nih.gov/24928772 Nom Autors Brana, Irene; Calles, Antonio; Calvo, Emiliano; de Boer, Carla J; LoRusso, Patricia M; Puchalski, Thomas A; Seetharam, Shobha; Tabernero, Josep; Yee, Lorrin K; Zhong, Bob et al. DOI número 10.1007/s11523-014-0320-2 Year 2015 Referencia J Clin Oncol. 2015 Nov 10;33(32):3733-40. doi: 10.1200/JCO.2015.60.9107. Epub 2015 Aug 31. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2015.60.9107 Revista J CLIN ONCOL Títol Complet Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. Codi 54436 PMID https://pubmed.ncbi.nlm.nih.gov/26324362 Nom Autors de Braud, Filippo; Haller, Daniel G; Hill, Mark; Hoersch, Silke; Maroun, Jean; Price, Timothy; Rittweger, Karen; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, Eric et al. DOI número 10.1200/JCO.2015.60.9107 Year 2015 Referencia Lancet Oncol. 2015 Jun;16(6):e262. doi: 10.1016/S1470-2045(15)70273-1. Epub 2015 May 27. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)70273-1 Revista LANCET ONCOL Títol Complet Correction to Lancet Oncol 2015; 16: 499-508. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Codi 54434 PMID https://pubmed.ncbi.nlm.nih.gov/26065608 Nom Autors Cohn, A L; Tabernero, J; Takayuki, Y et al. DOI número 10.1016/S1470-2045(15)70273-1 Year 2015 Referencia Methods. 2015 May;77-78:25-30. doi: 10.1016/j.ymeth.2015.02.005. Epub 2015 Feb 16. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ymeth.2015.02.005 Revista METHODS Títol Complet Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN. Codi 54433 PMID https://pubmed.ncbi.nlm.nih.gov/25697760 Nom Autors Aransay, Ana M; Arrieta, Edurne; Arruabarrena-Aristorena, Amaia; Baselga, Jose; Bilbao, Elena; Bilbao, Roberto; Cachi-Fuentes, Guido; Caro-Maldonado, Alfredo; Carracedo, Arkaitz; Castillo-Martin, Mireia et al. DOI número 10.1016/j.ymeth.2015.02.005 Year 2015 Referencia Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1002/cncr.29537 Revista CANCER-AM CANCER SOC Títol Complet Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Autors Maria Buti Ferret Codi 54432 PMID https://pubmed.ncbi.nlm.nih.gov/26177866 Nom Autors Aguilar Schall, Raul E; Berg, Thomas; Buti, Maria; Dinh, Phillip V; Flaherty, John F; Fung, Scott; Gurel, Selim; Jacobson, Ira; Kim, W Ray; Loomba, Rohit et al. DOI número 10.1002/cncr.29537 Year 2015 Referencia J Clin Virol. 2015 Jul;68:56-60. doi: 10.1016/j.jcv.2015.05.010. Epub 2015 May 14. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jcv.2015.05.010 Revista J CLIN VIROL Títol Complet Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment. Autors Maria Buti Ferret Codi 54431 PMID https://pubmed.ncbi.nlm.nih.gov/26071337 Nom Autors Ampuero, Javier; Andrade, Raul J; Buti, Maria; Cabezas, Joaquin; Calleja, Jose Luis; Crespo, Javier; Del Campo, Jose Antonio; Fernandez, Inmaculada; Forns, Xavier; Lens, Sabela et al. DOI número 10.1016/j.jcv.2015.05.010 Year 2015 Referencia Ann Hepatol. 2015 Jul-Aug;14(4):477-86. Tipus publicació Paper in international publication DOI http://dx.doi.org/ Revista ANN HEPATOL Títol Complet High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain. Autors Maria Buti Ferret Codi 54430 PMID https://pubmed.ncbi.nlm.nih.gov/26019034 Nom Autors Berenguer, Marina; Broquetas, Teresa; Buti, Maria; Cabezas, Joaquin; Calleja, Jose Luis; Crespo, Javier; Cuadrado, Antonio; Diago, Moises; Fernandez, Conrado; Fernandez, Inmaculada et al. Year 2015 Referencia Gastroenterol Hepatol. 2015 Nov;38(9):517-24. doi: 10.1016/j.gastrohep.2015.04.002. Epub 2015 May 12. Tipus publicació Paper in national publication DOI http://dx.doi.org/10.1016/j.gastrohep.2015.04.002 Revista GASTROENT HEPAT-BARC Títol Complet [Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice]. Autors Maria Buti Ferret Oscar González López Codi 54429 PMID https://pubmed.ncbi.nlm.nih.gov/25976446 Nom Autors Barcena, Rafael; Berenguer, Marina; Buti, Maria; Calleja, Jose Luis; Crespo, Javier; Fernandez, Inmaculada; Gonzalez, Olga; Lopez, Jesus; Perez, Francisco et al. DOI número 10.1016/j.gastrohep.2015.04.002 Year 2015 Referencia J Viral Hepat. 2015 Sep;22(9):683-90. doi: 10.1111/jvh.12419. Epub 2015 May 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1111/jvh.12419 Revista J VIRAL HEPATITIS Títol Complet Therapy for hepatitis C genotype 3: moving forward. Autors Maria Buti Ferret Jordi Llaneras Artigues Maria del Mar Riveiro Barciela Codi 54428 PMID https://pubmed.ncbi.nlm.nih.gov/25967352 Nom Autors Buti, M; Esteban, R; Llaneras, J; Riveiro-Barciela, M et al. DOI número 10.1111/jvh.12419 Year 2015 Referencia Genes Immun. 2015 Jul-Aug;16(5):297-300. doi: 10.1038/gene.2015.14. Epub 2015 Apr 30. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/gene.2015.14 Revista GENES IMMUN Títol Complet Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection. Autors Maria Buti Ferret Codi 54427 PMID https://pubmed.ncbi.nlm.nih.gov/25928882 Nom Autors Ampuero, J; Andrade, R; Buti, M; Calleja, J L; del Campo, J A; Diago, M; Forns, X; Garcia-Lozano, R J; Garcia-Samaniego, J; Garcia-Valdecasas, M et al. DOI número 10.1038/gene.2015.14 Pagination First page « Previous page ‹ … Page 1786 Page 1787 Current page 1788 Page 1789 Page 1790 … Next page › Last page »
Year 2015 Referencia Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub 2015 Jan 14. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s13402-014-0203-7 Revista CELL ONCOL Títol Complet Intrinsic cancer subtypes--next steps into personalized medicine. Codi 54447 PMID https://pubmed.ncbi.nlm.nih.gov/25586691 Nom Autors Dienstmann, Rodrigo; Grasselli, Julieta; Moreno, Victor; Nadal, Ernest; Pernas, Sonia; Salazar, Ramon; Santos, Cristina; Sanz-Pamplona, Rebeca; Tabernero, Josep et al. DOI número 10.1007/s13402-014-0203-7
Year 2015 Referencia J Clin Oncol. 2015 Jun 1;33(16):1787-96. doi: 10.1200/JCO.2014.60.0213. Epub 2015 Apr 27. Tipus publicació Review in national publication DOI http://dx.doi.org/10.1200/JCO.2014.60.0213 Revista J CLIN ONCOL Títol Complet Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients. Codi 54446 PMID https://pubmed.ncbi.nlm.nih.gov/25918287 Nom Autors Dienstmann, Rodrigo; Salazar, Ramon; Tabernero, Josep et al. DOI número 10.1200/JCO.2014.60.0213
Year 2015 Referencia Clin Cancer Res. 2015 Nov 1;21(21):4811-8. doi: 10.1158/1078-0432.CCR-14-3222. Epub 2015 Jul 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1078-0432.CCR-14-3222 Revista CLIN CANCER RES Títol Complet SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial. Codi 54445 PMID https://pubmed.ncbi.nlm.nih.gov/26169969 Nom Autors Brachmann, Carrie B; Heise, Carla; Hidalgo, Manuel; Illei, Peter; Lopez-Casas, Pedro P; Lopez-Rios, Fernando; Menendez, Camino; Musteanu, Monica; Pierce, Daniel; Plaza, Carlos et al. DOI número 10.1158/1078-0432.CCR-14-3222
Year 2015 Referencia Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)70127-0 Revista LANCET ONCOL Títol Complet Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Codi 54444 PMID https://pubmed.ncbi.nlm.nih.gov/25877855 Nom Autors Achille, Emmanuel; Acs, Peter; Ahn, Joong Bae; Al-batran, Salah-eddin; Anderson, Thomas; Andrews, Willard; Atkinson, Victoria; Awasthi, Sanjay; Ayers, John; Azad, Niolfer et al. DOI número 10.1016/S1470-2045(15)70127-0
Year 2015 Referencia N Engl J Med. 2015 Aug 20;373(8):726-36. doi: 10.1056/NEJMoa1502309. Tipus publicació Clinical guide DOI http://dx.doi.org/10.1056/NEJMoa1502309 Revista NEW ENGL J MED Títol Complet Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. Codi 54443 PMID https://pubmed.ncbi.nlm.nih.gov/26287849 Nom Autors Baselga, Jose; Blay, Jean-Yves; Chan, Emily; Chau, Ian; Diamond, Eli L; Elez-Fernandez, Maria Elena; Faris, Jason E; Gervais, Radj; Hidalgo, Manuel; Hofheinz, Ralf-Dieter et al. DOI número 10.1056/NEJMoa1502309
Year 2015 Referencia Cancer Discov. 2015 Jun;5(6):598-609. doi: 10.1158/2159-8290.CD-14-1432. Epub 2015 May 11. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/2159-8290.CD-14-1432 Revista CANCER DISCOV Títol Complet Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer. Codi 54442 PMID https://pubmed.ncbi.nlm.nih.gov/25962717 Nom Autors Argiles, Guillem; Benavent, Marta; Braun, Stephan; Cervantes, Andres; Dienstmann, Rodrigo; Garcia-Carbonero, Rocio; Hald, Rikke; Hansen, Ulla H; Horak, Ivan D; Kragh, Michael et al. DOI número 10.1158/2159-8290.CD-14-1432
Year 2015 Referencia Lancet Oncol. 2015 Aug;16(8):937-48. doi: 10.1016/S1470-2045(15)00138-2. Epub 2015 Jul 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)00138-2 Revista LANCET ONCOL Títol Complet Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial. Codi 54441 PMID https://pubmed.ncbi.nlm.nih.gov/26184520 Nom Autors Adenis, Antoine; Barone, Carlo; Bouche, Olivier; Falcone, Alfredo; Goldberg, Richard M; Grothey, Axel; Humblet, Yves; Jeffers, Michael; Laurent, Dirk; Lenz, Heinz-Josef et al. DOI número 10.1016/S1470-2045(15)00138-2
Year 2015 Referencia N Engl J Med. 2015 May 14;372(20):1909-19. doi: 10.1056/NEJMoa1414325. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1056/NEJMoa1414325 Revista NEW ENGL J MED Títol Complet Randomized trial of TAS-102 for refractory metastatic colorectal cancer. Codi 54440 PMID https://pubmed.ncbi.nlm.nih.gov/25970050 Nom Autors Adenis, Antoine; Andre, Thierry; Baba, Hideo; Baron, Ari D; Benavides, Manuel; Benedetti, Fabio; Bertolini, Alessandro; Bird, Brian; Block, Andreas; Borg, Christophe et al. DOI número 10.1056/NEJMoa1414325
Year 2015 Referencia Cancer Discov. 2015 Nov;5(11):1164-77. doi: 10.1158/2159-8290.CD-15-0369. Epub 2015 Sep 26. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/2159-8290.CD-15-0369 Revista CANCER DISCOV Títol Complet Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. Autors Elena Antima Martinez Saez Codi 54439 PMID https://pubmed.ncbi.nlm.nih.gov/26410082 Nom Autors Barker, Frederick G 2nd; Baselga, Jose; Batchelor, Tracy T; Beroukhim, Rameen; Brastianos, Priscilla K; Cahill, Daniel P; Carter, Scott L; Chevalier, Aaron; Choueiri, Toni K; Cibulskis, Kristian et al. DOI número 10.1158/2159-8290.CD-15-0369
Year 2015 Referencia Am Soc Clin Oncol Educ Book. 2015;35:e149-56. doi: 10.14694/EdBook_AM.2015.35.e149. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.14694/EdBook_AM.2015.35.e149 Revista American Society of Clinical Oncology educational Títol Complet Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer. Codi 54438 PMID https://pubmed.ncbi.nlm.nih.gov/25993166 Nom Autors Dienstmann, Rodrigo; Salazar, Ramon; Tabernero, Josep et al. DOI número 10.14694/EdBook_AM.2015.35.e149
Year 2015 Referencia Target Oncol. 2015 Mar;10(1):111-23. doi: 10.1007/s11523-014-0320-2. Epub 2014 Jun 15. Tipus publicació Clinical Trials DOI http://dx.doi.org/10.1007/s11523-014-0320-2 Revista TARGET ONCOL Títol Complet Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study. Codi 54437 PMID https://pubmed.ncbi.nlm.nih.gov/24928772 Nom Autors Brana, Irene; Calles, Antonio; Calvo, Emiliano; de Boer, Carla J; LoRusso, Patricia M; Puchalski, Thomas A; Seetharam, Shobha; Tabernero, Josep; Yee, Lorrin K; Zhong, Bob et al. DOI número 10.1007/s11523-014-0320-2
Year 2015 Referencia J Clin Oncol. 2015 Nov 10;33(32):3733-40. doi: 10.1200/JCO.2015.60.9107. Epub 2015 Aug 31. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2015.60.9107 Revista J CLIN ONCOL Títol Complet Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial. Codi 54436 PMID https://pubmed.ncbi.nlm.nih.gov/26324362 Nom Autors de Braud, Filippo; Haller, Daniel G; Hill, Mark; Hoersch, Silke; Maroun, Jean; Price, Timothy; Rittweger, Karen; Schmoll, Hans-Joachim; Tabernero, Josep; Van Cutsem, Eric et al. DOI número 10.1200/JCO.2015.60.9107
Year 2015 Referencia Lancet Oncol. 2015 Jun;16(6):e262. doi: 10.1016/S1470-2045(15)70273-1. Epub 2015 May 27. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1016/S1470-2045(15)70273-1 Revista LANCET ONCOL Títol Complet Correction to Lancet Oncol 2015; 16: 499-508. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Codi 54434 PMID https://pubmed.ncbi.nlm.nih.gov/26065608 Nom Autors Cohn, A L; Tabernero, J; Takayuki, Y et al. DOI número 10.1016/S1470-2045(15)70273-1
Year 2015 Referencia Methods. 2015 May;77-78:25-30. doi: 10.1016/j.ymeth.2015.02.005. Epub 2015 Feb 16. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ymeth.2015.02.005 Revista METHODS Títol Complet Methodological aspects of the molecular and histological study of prostate cancer: focus on PTEN. Codi 54433 PMID https://pubmed.ncbi.nlm.nih.gov/25697760 Nom Autors Aransay, Ana M; Arrieta, Edurne; Arruabarrena-Aristorena, Amaia; Baselga, Jose; Bilbao, Elena; Bilbao, Roberto; Cachi-Fuentes, Guido; Caro-Maldonado, Alfredo; Carracedo, Arkaitz; Castillo-Martin, Mireia et al. DOI número 10.1016/j.ymeth.2015.02.005
Year 2015 Referencia Cancer. 2015 Oct 15;121(20):3631-8. doi: 10.1002/cncr.29537. Epub 2015 Jul 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1002/cncr.29537 Revista CANCER-AM CANCER SOC Títol Complet Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Autors Maria Buti Ferret Codi 54432 PMID https://pubmed.ncbi.nlm.nih.gov/26177866 Nom Autors Aguilar Schall, Raul E; Berg, Thomas; Buti, Maria; Dinh, Phillip V; Flaherty, John F; Fung, Scott; Gurel, Selim; Jacobson, Ira; Kim, W Ray; Loomba, Rohit et al. DOI número 10.1002/cncr.29537
Year 2015 Referencia J Clin Virol. 2015 Jul;68:56-60. doi: 10.1016/j.jcv.2015.05.010. Epub 2015 May 14. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jcv.2015.05.010 Revista J CLIN VIROL Títol Complet Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment. Autors Maria Buti Ferret Codi 54431 PMID https://pubmed.ncbi.nlm.nih.gov/26071337 Nom Autors Ampuero, Javier; Andrade, Raul J; Buti, Maria; Cabezas, Joaquin; Calleja, Jose Luis; Crespo, Javier; Del Campo, Jose Antonio; Fernandez, Inmaculada; Forns, Xavier; Lens, Sabela et al. DOI número 10.1016/j.jcv.2015.05.010
Year 2015 Referencia Ann Hepatol. 2015 Jul-Aug;14(4):477-86. Tipus publicació Paper in international publication DOI http://dx.doi.org/ Revista ANN HEPATOL Títol Complet High efficacy and safety of triple therapy in HCV genotype 1 and moderate fibrosis: a multicenter study of clinical practice in Spain. Autors Maria Buti Ferret Codi 54430 PMID https://pubmed.ncbi.nlm.nih.gov/26019034 Nom Autors Berenguer, Marina; Broquetas, Teresa; Buti, Maria; Cabezas, Joaquin; Calleja, Jose Luis; Crespo, Javier; Cuadrado, Antonio; Diago, Moises; Fernandez, Conrado; Fernandez, Inmaculada et al.
Year 2015 Referencia Gastroenterol Hepatol. 2015 Nov;38(9):517-24. doi: 10.1016/j.gastrohep.2015.04.002. Epub 2015 May 12. Tipus publicació Paper in national publication DOI http://dx.doi.org/10.1016/j.gastrohep.2015.04.002 Revista GASTROENT HEPAT-BARC Títol Complet [Lead-in period and week 8 as predictive tools for response to boceprevir therapy: a retrospective study of Spanish real clinical practice]. Autors Maria Buti Ferret Oscar González López Codi 54429 PMID https://pubmed.ncbi.nlm.nih.gov/25976446 Nom Autors Barcena, Rafael; Berenguer, Marina; Buti, Maria; Calleja, Jose Luis; Crespo, Javier; Fernandez, Inmaculada; Gonzalez, Olga; Lopez, Jesus; Perez, Francisco et al. DOI número 10.1016/j.gastrohep.2015.04.002
Year 2015 Referencia J Viral Hepat. 2015 Sep;22(9):683-90. doi: 10.1111/jvh.12419. Epub 2015 May 13. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1111/jvh.12419 Revista J VIRAL HEPATITIS Títol Complet Therapy for hepatitis C genotype 3: moving forward. Autors Maria Buti Ferret Jordi Llaneras Artigues Maria del Mar Riveiro Barciela Codi 54428 PMID https://pubmed.ncbi.nlm.nih.gov/25967352 Nom Autors Buti, M; Esteban, R; Llaneras, J; Riveiro-Barciela, M et al. DOI número 10.1111/jvh.12419
Year 2015 Referencia Genes Immun. 2015 Jul-Aug;16(5):297-300. doi: 10.1038/gene.2015.14. Epub 2015 Apr 30. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/gene.2015.14 Revista GENES IMMUN Títol Complet Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection. Autors Maria Buti Ferret Codi 54427 PMID https://pubmed.ncbi.nlm.nih.gov/25928882 Nom Autors Ampuero, J; Andrade, R; Buti, M; Calleja, J L; del Campo, J A; Diago, M; Forns, X; Garcia-Lozano, R J; Garcia-Samaniego, J; Garcia-Valdecasas, M et al. DOI número 10.1038/gene.2015.14
